Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...
Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.
12h
News Medical on MSNHealthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortagesToday, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading organizations and providers across ...
4hon MSN
North Carolina State Treasurer Brad Briner spoke with WRAL News about plans to tackle the state health plan deficit, bringing ...
1h
WOODTV.com on MSNIs ‘microdosing’ Ozempic becoming a trend?The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a ...
3hOpinion
Sentinel & Enterprise on MSNEditorial: Reforms crucial Rx for containing cost of Mass. health careOnly time will tell if the recently enacted health-care reform laws can rein in the uncontrollable costs that have created ...
Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results